| Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline M Fleseriu, IA Hashim, N Karavitaki, S Melmed, MH Murad, R Salvatori, ... The Journal of Clinical Endocrinology & Metabolism 101 (11), 3888-3921, 2016 | 757 | 2016 |
| Endocrine side effects induced by immune checkpoint inhibitors SM Corsello, A Barnabei, P Marchetti, L De Vecchis, R Salvatori, F Torino The Journal of Clinical Endocrinology & Metabolism 98 (4), 1361-1375, 2013 | 464 | 2013 |
| Consensus on diagnosis and management of Cushing's disease: a guideline update M Fleseriu, R Auchus, I Bancos, A Ben-Shlomo, J Bertherat, NR Biermasz, ... The lancet Diabetes & endocrinology 9 (12), 847-875, 2021 | 404 | 2021 |
| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 395 | 2010 |
| Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene R Salvatori, CY Hayashida, MH Aguiar-Oliveira, JA Phillips III, AHO Souza, ... The Journal of Clinical Endocrinology & Metabolism 84 (3), 917-923, 1999 | 289 | 1999 |
| A consensus on the diagnosis and treatment of acromegaly comorbidities: an update A Giustina, A Barkan, A Beckers, N Biermasz, BMK Biller, C Boguszewski, ... The Journal of Clinical Endocrinology & Metabolism 105 (4), e937-e946, 2020 | 279 | 2020 |
| Multidisciplinary management of acromegaly: a consensus A Giustina, G Barkhoudarian, A Beckers, A Ben-Shlomo, N Biermasz, ... Reviews in Endocrine and Metabolic Disorders 21, 667-678, 2020 | 238 | 2020 |
| The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and … CA Stratakis, MA Tichomirowa, S Boikos, MF Azevedo, M Lodish, ... Clinical genetics 78 (5), 457-463, 2010 | 220 | 2010 |
| Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients L Rostomyan, AF Daly, P Petrossians, E Nachev, AR Lila, AL Lecoq, ... Endocrine-related cancer 22 (5), 745-757, 2015 | 186 | 2015 |
| X-linked acrogigantism syndrome: clinical profile and therapeutic responses A Beckers, MB Lodish, G Trivellin, L Rostomyan, M Lee, FR Faucz, ... Endocrine-related cancer 22 (3), 353-367, 2015 | 178 | 2015 |
| Effects of an oral growth hormone secretagogue in older adults HK White, CD Petrie, W Landschulz, D MacLean, A Taylor, K Lyles, ... The Journal of Clinical Endocrinology & Metabolism 94 (4), 1198-1206, 2009 | 159 | 2009 |
| Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach MD Gahete, J Córdoba-Chacón, R Salvatori, JP Castaño, RD Kineman, ... Molecular and cellular endocrinology 317 (1-2), 154-160, 2010 | 148 | 2010 |
| Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis AR Moliterno, DM Williams, LI Gutierrez-Alamillo, R Salvatori, ... Proceedings of the National Academy of Sciences 101 (31), 11444-11447, 2004 | 143 | 2004 |
| Recurrence of hyperprolactinemia after withdrawal of long-term cabergoline therapy J Kharlip, R Salvatori, G Yenokyan, GS Wand The Journal of Clinical Endocrinology & Metabolism 94 (7), 2428-2436, 2009 | 142 | 2009 |
| Endocrinological side-effects of immune checkpoint inhibitors F Torino, SM Corsello, R Salvatori Current opinion in oncology 28 (4), 278-287, 2016 | 141 | 2016 |
| Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial A Lacroix, F Gu, W Gallardo, R Pivonello, Y Yu, P Witek, M Boscaro, ... The Lancet Diabetes & Endocrinology 6 (1), 17-26, 2018 | 140 | 2018 |
| Current best practice in the management of patients after pituitary surgery A Prete, SM Corsello, R Salvatori Therapeutic advances in endocrinology and metabolism 8 (3), 33-48, 2017 | 136 | 2017 |
| A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency M Alba, R Salvatori Endocrinology 145 (9), 4134-4143, 2004 | 136 | 2004 |
| Adrenal insufficiency R Salvatori Jama 294 (19), 2481-2488, 2005 | 135 | 2005 |
| Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice LY Sun, A Spong, WR Swindell, Y Fang, C Hill, JA Huber, JD Boehm, ... Elife 2, e01098, 2013 | 134 | 2013 |
